Johnson & Johnson says it will end sales of talcum-based baby powder in North America after facing thousands of lawsuits from cancer patients. 

Johnson & Johnson says new testing of a batch of baby powder that was recently recalled did not show any traces of asbestos.

Stocks ended the week with a steep loss on Wall Street as the S&P 500 dropped to its lowest level since April.

A Los Angeles jury has ordered Johnson & Johnson to pay $417 million in a case to a woman who claimed in a lawsuit that the talc in the company's iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene.